RU93058563A - POLYEPEPTIDES, IMMUNOR REAGENT, METHOD FOR DETERMINING ANTIBODIES, METHOD FOR INDUCING AN IMMUNE RESPONSE, COMPOSITION, METHOD FOR PRODUCING A POLYEPEPTIDE - Google Patents

POLYEPEPTIDES, IMMUNOR REAGENT, METHOD FOR DETERMINING ANTIBODIES, METHOD FOR INDUCING AN IMMUNE RESPONSE, COMPOSITION, METHOD FOR PRODUCING A POLYEPEPTIDE

Info

Publication number
RU93058563A
RU93058563A RU93058563/04A RU93058563A RU93058563A RU 93058563 A RU93058563 A RU 93058563A RU 93058563/04 A RU93058563/04 A RU 93058563/04A RU 93058563 A RU93058563 A RU 93058563A RU 93058563 A RU93058563 A RU 93058563A
Authority
RU
Russia
Prior art keywords
immunor
polyepeptides
polyepeptide
inducing
reagent
Prior art date
Application number
RU93058563/04A
Other languages
Russian (ru)
Other versions
RU2148587C1 (en
Inventor
Ю.Чин Дэвид
Раттер Вилльям
Original Assignee
Чирон Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чирон Корпорейшн filed Critical Чирон Корпорейшн
Priority claimed from PCT/US1992/005388 external-priority patent/WO1993000365A2/en
Publication of RU93058563A publication Critical patent/RU93058563A/en
Application granted granted Critical
Publication of RU2148587C1 publication Critical patent/RU2148587C1/en

Links

Claims (1)

Раскрываются эпитопы HCV, применимые в качестве иммуногенных реагентов, и соответствующие антитела и способы применения.HCV epitopes useful as immunogenic reagents and corresponding antibodies and methods of administration are disclosed.
RU93058563A 1991-06-24 1992-06-24 Polypeptide and method of its synthesis, reagent for immuno-analysis, method of assay of antibody presence, method of induction of immune response RU2148587C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72248991A 1991-06-24 1991-06-24
US722,489 1991-06-24
US722489 1991-06-24
PCT/US1992/005388 WO1993000365A2 (en) 1991-06-24 1992-06-24 Hepatitis c virus (hcv) polypeptides

Publications (2)

Publication Number Publication Date
RU93058563A true RU93058563A (en) 1996-12-27
RU2148587C1 RU2148587C1 (en) 2000-05-10

Family

ID=24902063

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93058563A RU2148587C1 (en) 1991-06-24 1992-06-24 Polypeptide and method of its synthesis, reagent for immuno-analysis, method of assay of antibody presence, method of induction of immune response

Country Status (16)

Country Link
US (2) US6346375B1 (en)
EP (1) EP0591431B1 (en)
JP (9) JP3516681B2 (en)
KR (1) KR0185426B1 (en)
AT (1) ATE229543T1 (en)
BG (1) BG61843B1 (en)
CA (1) CA2110058C (en)
DE (1) DE69232871T2 (en)
ES (1) ES2188583T3 (en)
FI (2) FI110099B (en)
HU (1) HU227547B1 (en)
NO (1) NO309528B1 (en)
RO (1) RO117329B1 (en)
RU (1) RU2148587C1 (en)
UA (1) UA40572C2 (en)
WO (1) WO1993000365A2 (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
GB9204274D0 (en) * 1992-02-28 1992-04-08 Wellcome Found Novel peptides
US6667387B1 (en) 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
DE4240980A1 (en) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh HCV peptide antigens and method for the determination of HCV
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
BR9405334A (en) 1993-04-27 1999-05-25 Innogenetics Nv New hepatitis c virus genotype sequences and their use as therapeutic and diagnostic agents
PL175338B1 (en) * 1993-05-10 1998-12-31 Chiron Corp Polypeptide and reagent for classifying one or more types hepatitic c virus (hcv)
ATE249838T1 (en) 1993-05-12 2003-10-15 Chiron Corp PRESERVED MOTIF OF THE HEPATITIS C VIRUS E2/NS1 REGION
US5514539A (en) * 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5639856A (en) * 1993-09-13 1997-06-17 The Regents Of The University Of California Semaphorin gene family
AU8003894A (en) * 1993-10-29 1995-05-22 Srl Inc. Antigen peptide compound and immunoassay method
EP0979867A3 (en) * 1993-11-04 2007-06-13 Innogenetics N.V. Immunodominant human T-cell epitopes of hepatitis C virus
US5709995A (en) 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
AU702436B2 (en) * 1994-10-21 1999-02-18 Innogenetics N.V. New sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
GB2294690B (en) * 1994-11-01 1998-10-28 United Biomedical Inc Peptides effective for diagnosis and detection of hepatitis C infection
US6034064A (en) * 1995-04-07 2000-03-07 Hoechst Pharmaceuticals & Chemicals K.K. Peptides and therapeutic agent for autoimmune diseases containing the same
JPH08333390A (en) * 1995-04-07 1996-12-17 Hoechst Japan Ltd Peptide and autoimmune disease-treating medicine comprising the same
AU2352995A (en) * 1995-04-28 1996-11-18 Srl Inc. Antigen peptide compound and immunoassay method
GB9513261D0 (en) * 1995-06-29 1995-09-06 Smithkline Beecham Biolog Vaccines
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
EP0935662B1 (en) * 1996-05-24 2005-11-30 Chiron Corporation Multiple epitope fusion protein
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
DE69840334D1 (en) 1997-09-22 2009-01-22 Novartis Vaccines & Diagnostic BUFFERS FOR STABILIZING HCV ANTIGENES
PT1071955E (en) 1998-04-17 2005-02-28 Innogenetics Nv IMMUNOLOGICAL DIAGNOSTIC IMPROVED ASSAYS USING REDUCING AGENTS
US7052830B1 (en) * 1998-06-09 2006-05-30 Branch Andrea D Hepatitis C virus peptides and uses thereof
US7052696B2 (en) * 1998-07-10 2006-05-30 The United States Of America As Represented By The Department Of Health And Human Services Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins
US6191256B1 (en) * 1998-11-20 2001-02-20 Bayer Corporation Recombinant factor VIII binding peptides
EP1200109A4 (en) * 1999-07-19 2005-06-15 Epimmune Inc Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
CN100463922C (en) 2000-06-15 2009-02-25 诺华疫苗和诊断公司 Immunoassays for anti-HCV antibodies
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
RU2286172C2 (en) 2000-08-17 2006-10-27 Трипеп Аб Ribavirin-containing vaccines and methods for their application
EP2332574A1 (en) 2000-08-17 2011-06-15 Tripep Ab HCV NS3/4A Sequences
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
EP1195381A1 (en) * 2000-09-28 2002-04-10 Immusystems GmbH Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes
EP1414942A2 (en) 2001-04-24 2004-05-06 Innogenetics N.V. Expression of core-glycosylated hcv envelope proteins in yeast
AU2002311897A1 (en) * 2001-05-09 2002-11-18 Third Wave Technologies, Inc. Nucleic acid detection in pooled samples
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US20030100467A1 (en) * 2001-09-12 2003-05-29 Wolfgang Aehle Binding phenol oxidizing enzyme-peptide complexes
AR045702A1 (en) * 2001-10-03 2005-11-09 Chiron Corp COMPOSITIONS OF ASSISTANTS.
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
EP1483575A2 (en) * 2002-02-28 2004-12-08 Intercell AG Methods for isolating ligands e.g. t cell epitopes
ES2386742T3 (en) * 2002-03-11 2012-08-28 Lab 21 Limited Method and compositions to identify and characterize Hepatitis C
US7201904B2 (en) * 2002-05-16 2007-04-10 The General Hospital Corporation Epitopes of hepatitis C virus
FR2839722A1 (en) * 2002-05-17 2003-11-21 Bio Merieux Combination of peptides, useful for treatment, prevention or diagnosis of hepatitis C infection
US7528223B2 (en) 2002-07-24 2009-05-05 Intercell Ag Antigens encoded by alternative reading frames from pathogenic viruses
JP4585314B2 (en) 2002-09-09 2010-11-24 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド HCV assay
WO2004024182A2 (en) * 2002-09-13 2004-03-25 Intercell Ag Method for isolating hepatitis c virus peptides
CN102512670A (en) * 2003-03-04 2012-06-27 英特塞尔股份公司 Streptococcus pyogenes antigens
AU2004224746B2 (en) 2003-03-24 2009-04-23 Valneva Austria Gmbh Improved vaccines
CN100355453C (en) * 2003-03-24 2007-12-19 英特塞尔股份公司 Improved vaccines
EP2298934A1 (en) 2003-04-15 2011-03-23 Intercell AG S. pneumoniae antigens
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
DE602004030343D1 (en) 2003-07-11 2011-01-13 Intercell Ag HCV VACCINE
US20050202036A1 (en) * 2003-07-22 2005-09-15 Branch Andrea D. Alternate reading frame polypeptides drived from hepatitis C and methods of their use
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
FR2859909B1 (en) 2003-09-22 2007-09-07 Biomerieux Sa PROCESS FOR THE PREPARATION OF BIORESORBABLE MICROPARTICLES, MICROPARTICLES OBTAINED AND USE
EP1735336A2 (en) * 2004-04-16 2006-12-27 Genentech, Inc. Omi pdz modulators
WO2006024020A2 (en) * 2004-08-27 2006-03-02 Novartis Vaccines And Diagnostics Inc. Hcv non-structural protein mutants and uses thereof
WO2006126102A2 (en) * 2005-04-20 2006-11-30 Viromed Co., Ltd. Compositions and methods for fusion protein separation
CA2618429A1 (en) * 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
JP5474547B2 (en) 2006-08-25 2014-04-16 ノバルティス アーゲー HCV fusion polypeptide
JP4975600B2 (en) * 2007-03-16 2012-07-11 シスメックス株式会社 Reagent kit for HCV antibody measurement and HCV antibody measurement method
EP2185195A2 (en) 2007-08-16 2010-05-19 Tripep Ab Immunogen platform
JP2011506334A (en) 2007-12-07 2011-03-03 ノバルティス アーゲー Composition for inducing an immune response
WO2009130588A2 (en) * 2008-04-22 2009-10-29 Tripep Ab Immunogen platform
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
MX350258B (en) 2011-07-06 2017-08-31 Novartis Ag Cationic oil-in-water emulsions.
MX350198B (en) 2011-07-06 2017-08-30 Novartis Ag Oil-in-water emulsions that contain nucleic acids.
FR2984328B1 (en) 2011-12-20 2016-12-30 Bio-Rad Innovations METHOD FOR DETECTING HEPATITIS C VIRUS INFECTION
WO2013150450A1 (en) * 2012-04-02 2013-10-10 Universidade Do Porto Hcv homolog fragments, cell-lines and applications thereof
JP2016512241A (en) 2013-03-14 2016-04-25 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ HCVNS3 recombinant antigen for improved antibody detection and mutants thereof
EP2968526A4 (en) 2013-03-14 2016-11-09 Abbott Lab Hcv antigen-antibody combination assay and methods and compositions for use therein
JP6739329B2 (en) 2013-03-14 2020-08-12 アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ HCV core lipid binding domain monoclonal antibody
CN107735499B (en) 2015-03-27 2022-05-03 奥索临床诊断有限公司 HCV NS 4A/modified NS3 polypeptides and uses thereof
CN111153963B (en) * 2020-01-19 2021-08-10 华南理工大学 Anti-inflammatory pentapeptide, extraction and separation method thereof and application of anti-inflammatory pentapeptide in memory improvement

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861588A (en) * 1985-02-05 1989-08-29 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
DE318216T1 (en) * 1987-11-18 1990-06-13 Chiron Corp., Emeryville, Calif., Us NANBV DIAGNOSTICS AND VACCINE.
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
YU48038B (en) 1987-11-18 1996-10-18 Chiron Corp. PROCEDURE FOR DIAGNOSIS OF NO-A, NO-V HEPATITIS
US5312737A (en) 1988-03-11 1994-05-17 Abbott Laboratories CKS method of HCV protein synthesis
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
EP0416725A3 (en) 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
JP2818761B2 (en) 1989-09-14 1998-10-30 財団法人化学及血清療法研究所 Nucleic acid fragment encoding non-A non-B hepatitis virus antigen and use thereof
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
CA2065287C (en) * 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates
IT1242183B (en) * 1989-12-18 1994-02-16 Wellcome Found NON-A AND NON-B HEPATITIS VIRUS POLYPEPTIDES, POST-TRANSFUSIONAL, PRODUCTION PROCESS AND TESTING OF THE RELATIVE VIRAL NUCLEIC ACIDS.
JPH03190898A (en) 1989-12-21 1991-08-20 Shima Kenkyusho:Kk Synthetic polypeptide and reagent for hcv antibody analysis using same polypeptide
AU638304B2 (en) * 1989-12-22 1993-06-24 Abbott Laboratories Hepatitis c assay
EP0435229A1 (en) 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
KR940000755B1 (en) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Synthetic peptides specific for the detection of antibodies to hcv
AU7675491A (en) 1990-04-04 1991-10-30 Chiron Corporation Hepatitis c virus protease
DK0527815T3 (en) * 1990-04-06 2000-11-06 Genelabs Tech Inc Hepatitis C virus epitope
JPH044880A (en) 1990-04-20 1992-01-09 Terumasa Arima Dna coding hepatitis non-a and non-b antigen and polypeptide
JP3268502B2 (en) 1990-06-12 2002-03-25 徹雄 中村 Non-A non-B hepatitis virus-related polynucleotide, polypeptide
JPH0446196A (en) 1990-06-13 1992-02-17 Kuraray Co Ltd Antigen protein and dna fragment to code the same protein
FI913068A (en) 1990-06-25 1991-12-26 Univ Osaka Res Found NON-A-, NON-B-HEPATITISVIRUS PARTICLAR.
EP0933426A1 (en) 1990-06-25 1999-08-04 The Research Foundation for Microbial Diseases of Osaka University Non-a, non-b hepatitis virus genomic cdna fragments and antigen polypeptides
KR0181517B1 (en) 1990-07-09 1999-04-01 나까하라 노부유끼 Non-a, non-b hepatitis-specific antigen and its use in hepatitis diagnosis
JPH04126086A (en) 1990-07-12 1992-04-27 Yamanouchi Pharmaceut Co Ltd Antigen polypeptide against non-a and non-b type hepatitis virus, polynucleotide coding same polypeptide and diagnosis of non-a and non-b type hepatitis using them
CA2047792C (en) 1990-07-26 2002-07-02 Chang Y. Wang Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
PL169035B1 (en) 1990-08-10 1996-05-31 Chiron Corp Method of detecting hcv sequence
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
KR920004577A (en) 1990-08-24 1992-03-27 원본미기재 CKS Method of Protein Synthesis
AU673135B2 (en) 1990-08-25 1996-10-31 New York Blood Center, Inc., The Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines
JP3055793B2 (en) 1990-09-07 2000-06-26 財団法人化学及血清療法研究所 Non-A non-B hepatitis virus fusion peptide and method for producing the same
JPH04144686A (en) 1990-10-04 1992-05-19 Kunitada Shimotoono Structural protein gene, recombinant vector, escherichia coli transformed therewith, polypeptide and its production
JPH04159298A (en) 1990-10-19 1992-06-02 Olympus Optical Co Ltd Hcv peptide
EP0770679B2 (en) 1990-11-03 2009-12-30 Siemens Healthcare Diagnostics Products GmbH HCV-specific peptides, preparations related to them and their use
EP0485209A1 (en) 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
JPH04179482A (en) 1990-11-11 1992-06-26 Kunitada Shimotoono Gene derived from hepatitis c virus
JPH04187090A (en) 1990-11-22 1992-07-03 Toshio Shikata Dna encoding hepatitis antigen of non-a non-b type and polypeptide
WO1992009634A1 (en) 1990-11-29 1992-06-11 Toray Industries, Incorporated Non-a non-b hepatitis virus antigen protein
ES2095852T3 (en) * 1990-12-14 1997-03-01 Innogenetics Nv SYNTHETIC ANTIGENS FOR THE DETECTION OF ANTIBODIES AGAINST THE HEPATITIS C VIRUS.
ATE167522T1 (en) 1991-01-31 1998-07-15 Abbott Lab MONOCLONAL ANTIBODIES AGAINST POSSIBLE HCV ENVELOPE REGIONS AND METHODS OF USING THEM
JP3244284B2 (en) 1991-02-14 2002-01-07 武田薬品工業株式会社 Method for measuring hepatitis C virus-related antibodies and antigens
US5574132A (en) 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
JPH0568562A (en) 1991-05-30 1993-03-23 Sanwa Kagaku Kenkyusho Co Ltd Cdna of human hepatitis c virus, its clone and their use
JP3055964B2 (en) 1991-05-31 2000-06-26 株式会社トクヤマ HCV antigen-active polypeptide, method for producing polypeptide, transformed Escherichia coli, and method for detecting anti-HCV antibody
FR2677372B1 (en) 1991-06-06 1994-11-10 Pasteur Institut NUCLEOTIDE AND PEPTIDE SEQUENCES OF A HEPATITIS C VIRUS ISOLATE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS.
WO1992022655A1 (en) 1991-06-10 1992-12-23 Lucky Limited Hepatitis c diagnostics and vaccines
CA2070952A1 (en) 1991-06-11 1992-12-12 Makoto Seki Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
AU648912B2 (en) 1991-06-13 1994-05-05 Dade International Inc. Immunoassay for non-A non-B hepatitis
JP3103180B2 (en) 1992-01-30 2000-10-23 昭和電工株式会社 Soft synthetic resin sheet
JP3190898B2 (en) 1998-11-09 2001-07-23 米沢日本電気株式会社 Notebook personal computer

Similar Documents

Publication Publication Date Title
RU93058563A (en) POLYEPEPTIDES, IMMUNOR REAGENT, METHOD FOR DETERMINING ANTIBODIES, METHOD FOR INDUCING AN IMMUNE RESPONSE, COMPOSITION, METHOD FOR PRODUCING A POLYEPEPTIDE
CA2110058A1 (en) Hepatitis c virus (hcv) polypeptides
EP0231914A3 (en) Htlv-iii envelope peptides
CA2162132A1 (en) Hepatitis b virus mutants, reagents and methods for detection
DK0733069T3 (en) Purified Primat CTLA-8 antigens and related reagents
CA2116348A1 (en) Sirs vaccine and diagnosis method
RU94024561A (en) IMMUNORACTIVE COMPOSITIONS, METHOD FOR PREPARING THE COMPOSITION, METHODS FOR OBTAINING AND DETECTING ANTIBODIES, DNA SET, HOST CELL, METHOD OF OBTAINING PROTEIN
CA2047792A1 (en) Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
DE68924850T2 (en) HETERO FUNCTIONAL CELLULAR IMMUNOLOGICAL REAGENTS, VACCINATES THEREOF AND METHOD OF USE.
KR870007282A (en) Method for producing hepatitis B virus protein from yeast
ES2094206T3 (en) AGGLUTINATION TEST IN COLUMNS AND DEVICE.
CA2032907A1 (en) Hepatitis c assay
KR940703851A (en) Hepatitis E Virus Peptide Antigen and Antibody (HEPATITIS E VIRUS PEPTIDE ANTIGENS AND ANTIBODIES)
ATE157774T1 (en) METHOD FOR DETECTING ALZHEIMER'S DISEASE
DK603087A (en) IMMUNOCHEMICAL METHOD DETERMINATION OF STABLE GLYCOSYLED HAEMOGLOBIN
KR920002629A (en) Amino Acid Residue Sequence of Hepatitis B Core Antigen
PT84976A (en) METHOD OF PRODUCING FELINE LEUKEMIA VIRUS ANTIGENS CONTAINING RECOMBINANT POLYPEPTIDES
DE3789597T2 (en) Detection of a single strain of chlamydia associated with respiratory diseases.
CA2095735A1 (en) Monoclonal antibodies to hepatitis c virus and method for using same
ZA878303B (en) A process for isolating and characterizing a new viral agent and its associated antigen,the antigen and viral agent obtained by this process,and detection procedures for non a,non b hepatitis using suitable immunological reagents
EP0441644A3 (en) Non-a, non-b hepatitis related nucleic acids, antigens, antibodies and their detection reagents
DE58902996D1 (en) METHOD FOR DETECTING ANTIBODY AGAINST ERYTHROCYTE-SPECIFIC ANTIGENS.
PL245361A1 (en) Method of obtaining antibodies specific for antigens isolated from human serum,in particular for the antigen hbs.
GR3036125T3 (en) Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines.
DK375388D0 (en) NANB Hepatitis Virus, Antigen and Immunological Reagent